Background Drug-coated balloons (DCB) can decrease the incidence of restenosis in the treatment of intracranial atherosclerotic stenosis (ICAS). This study aimed to assess the safety and efficacy of ...

Background We investigate the association of imaging biomarkers extracted from fully automated body composition analysis (BCA) of computed tomography (CT) angiography images of endovascularly treated ...

Objective To investigate the intracranial manifestations of these changes in patients with cerebral venous outflow disorders (CVD). Methods A retrospective chart review was conducted on 22 consecutive ...

Background Distal occlusions associated with incomplete reperfusion (expanded Thrombolysis in Cerebral Infarction, <eTICI 3) may not reperfuse spontaneously and thus prompt ischemia (ie, persistent ...

Correspondence to Dr Akash P Kansagra, Mallinckrodt Institute of Radiology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA; apkansagra{at}gmail.com Traumatic ...

Background Arteriovenous malformation (AVM)-associated aneurysms represent a high-risk feature predisposing them to rupture. Infratentorial AVMs have been shown to have a greater incidence of ...

Correspondence to Dr Ryan A McTaggart, Department of Diagnostic Imaging, Warren Alpert School of Medicine at Brown University, Rhode Island Hospital, 593 Eddy Street, Room 377, Providence, RI 02903, ...

Background The drug coated balloon is a promising endovascular therapy for intracranial atherosclerosis (ICAS), potentially combining the advantages of primary angioplasty and antiproliferative drugs.

Background and purpose Flow diversion is an innovative and increasingly used endovascular treatment for intracranial aneurysms. Its initial evaluation with the first devices available showed good ...

Objective To develop and validate a method for creating realistic, patient specific replicas of cerebral aneurysms by means of fused deposition modeling. Methods The luminal boundaries of 10 cerebral ...